PPG (NYSE:PPG) today announced that it will support EuroSkills Herning 2025, Europe’s largest vocational skills competition, which takes place Sept. 9-13, 2025, in Herning, Denmark. As the Main Skill Sponsor for the Painting and Decorating competition, the company will provide financial support and will also supply SIGMA COATINGS™ paints and PROGOLD™ sundries by PPG. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407512504/en/From...

Cargill is honored to win five 2025 Edison Awards, recognizing the company’s bold innovations that are shaping the future of food and agriculture. From advancing climate-smart farming to driving breakthroughs in nutrition and water access, each award-winning solution showcases how Cargill is building a more secure and resilient food system. The Edison Awards, named for inventor Thomas Edison, celebrate the best in innovation, recognizing products and teams that solve global challenges, shape m...

Procore Technologies, Inc. (NYSE: PCOR), a leading technology partner for every stage of construction, today released its first ever Future State of Construction Report, offering a data-driven look at the key trends and challenges shaping the construction industry across the next decade. The inaugural report pairs extensive research and expert analysis from leading voices in the industry with survey data from over 1,200 construction decision-makers in Australia, Canada, Ireland, New Zealand, S...

NielsenIQ (NIQ), a leader in consumer intelligence, today announced it has reached an agreement to acquire Gastrograph AI, a market leading discovery and inquiry platform for sensory insights. The acquisition further strengthens NIQ’s AI capabilities and competitive differentiation to provide CPG companies with the Full View™ of consumer behavior. Gastrograph AI supports some of the largest consumer brands in the world, utilizing predictive AI to develop, test, and reformulate products by mode...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor for the treatment of people with cystic fibrosis (CF). With this approval, the indication has been expanded to include all patients ages 2 years and older who have at least one non-class I mutation in the cystic fibrosis conductance regulator (CFTR) gene. “We have been work...